Biogen Idec, Inc. (BIIB) Tops Q3 Adj-EPS by 8c
Tweet Send to a FriendGet Alerts BIIB Hot Sheet
Price: $232.62 -0.19%
EPS Growth %: +40.7%
Financial Fact:
Net income: 292.13M
Today's EPS Names:
TARO, SENEA, UQM, More
EPS Growth %: +40.7%
Financial Fact:
Net income: 292.13M
Today's EPS Names:
TARO, SENEA, UQM, More
Trade BIIB Now!
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q3 EPS of $1.61, ex-items, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.27 billion.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- Biogen Idec (BIIB) Appoints Spyros Artavanis-Tsakonas as CSO
- Pandora Media (P) Reports In-Line Q1 EPS, Revenue & Guidance Beat
Create E-mail Alert Related Categories
Earnings, Hot Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
